Letizia Granieri
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.
Journal: Cell reports
Published: November 05, 2025
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
Journal: EMBO molecular medicine
Published: September 13, 2022
A Na+ /Ca2+ exchanger of the olive pathogen Pseudomonas savastanoi pv. savastanoi is critical for its virulence.
Journal: Molecular plant pathology
Published: March 27, 2019
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead.
Journal: Molecular & cellular oncology
Published: May 16, 2018
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.
Journal: Cell reports
Published: October 23, 2017
Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 29, 2016
High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor.
Journal: Oncotarget
Published: November 20, 2015
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: October 30, 2015
Antagonistic Effect of a Salivary Proline-Rich Peptide on the Cytosolic Ca2+ Mobilization Induced by Progesterone in Oral Squamous Cancer Cells.
Journal: PloS one
Published: April 27, 2015
Synthesis of new indole-based bisphosphonates and evaluation of their chelating ability in PE/CA-PJ15 cells.
Journal: European journal of medicinal chemistry
Published: April 01, 2015
Last Updated: 09/26/2026